Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Lauri E. Markowitz(Centers for Disease Control and Prevention), Elizabeth R. Unger(Centers for Disease Control and Prevention), Harrell W. Chesson(Centers for Disease Control and Prevention), Eileen F. Dunne, Mona Saraiya(Merck & Co., Inc., Rahway, NJ, USA (United States)), Herschel W. Lawson
Cited by 1,891
Related Papers
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
|The Lancet|2019|1.3k
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.
|PubMed|2015|1.1k
Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
|JNCI Journal of the National Cancer Institute|2013|997